Status:
RECRUITING
Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebje...
Detailed Description
If the patient accepts to participate and signed the project informed consent, their clinical record will be followed until the last patient included has been followed for six months.
Eligibility Criteria
Inclusion
- 18-years age or older
- admitted with acute decompensated heart failure for less than 48 h
Exclusion
- pacemaker
- not signed informed consent
- other heart rhythm than sinus rhythm or atrial fibrillation
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06532825
Start Date
August 1 2024
End Date
December 31 2025
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology department Y, Bispebjerg-Frederiksberg Hospital
Frederiksberg, Denmark, 2000